Talis Biomedical Competitors and Similar CompaniesClear all

Talis Biomedical's competitors and similar companies include ONRAD, Esaote, Adaptix and ANT Neuro.

	Talis Biomedical Talis Biomedical is a company specializing in biomedical diagnostics.	ONRAD A full-service radiology provider offering results-proven services including teleradiology solutions, on-site radiology and custom hybrid solutions.	Esaote Esaote is a company that produces medical diagnostic systems with a focus on ultrasound and magnetic resonance imaging (MRI) technologies.	Adaptix Adaptix provides technology to allow low-cost low-dose 3D imaging at the bedside or GP's clinic.	ANT Neuro ANT Neuro is a company that provides solutions for neuroscience and neurodiagnostics.
Founding Date	Founding Date 2010	Founding Date 1998	Founding Date 1982	Founding Date N/A	Founding Date 1996
Type	Type Public	Type Private	Type Private	Type Private	Type Subsidiary
Tags	Tags Healthcare medical diagnostics medical imaging medtech	Tags Healthcare medical diagnostics medical imaging medtech	Tags Healthcare medical diagnostics medical imaging medtech	Tags Healthcare medical diagnostics medical imaging medtech	Tags Healthcare medical diagnostics medical imaging medtech
Locations	Locations Menlo Park, US HQ Chicago, US Chicago, US	Locations Phoenix, US HQ	Locations Genova, IT HQ Firenze, IT	Locations Oxfordshire, GB HQ Chapelhall, GB Didcot, GB	Locations Hengelo, NL HQ Melbourne, AU Berlin, DE Hong Kong, HK Stevenage, GB Philadelphia, US
Employees	Employees 993% decrease	Employees 71	Employees 1,243	Employees 751% decrease	Employees 691% decrease
Financial
Revenue (est.)	Revenue (est.) $2.1m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) £125k (FY, 2018)	Revenue (est.) N/A
Cost of goods	Cost of goods $41k (FY, 2023)	Cost of goods N/A	Cost of goods N/A	Cost of goods £463.2k (FY, 2018)	Cost of goods N/A
Gross profit	Gross profit $2.1m (FY, 2023)	Gross profit N/A	Gross profit N/A	Gross profit (£338.2k) (FY, 2018)	Gross profit N/A
Net income	Net income ($62m) (FY, 2023)	Net income N/A	Net income N/A	Net income (£2.1m) (FY, 2018)	Net income N/A